• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,130.24 810.69
( 1.11%)
Global Indices
Nasdaq
46,525.67 -61.07
(-0.13%)
Dow Jones
6,603.69 7.37
(0.11%)
Hang Seng
53,576.26 452.77
(0.85%)
Nikkei 225
10,436.29 71.50
(0.69%)
Forex
USD-INR
93.02 -0.15
(-0.16%)
EUR-INR
107.32 -0.65
(-0.60%)
GBP-INR
123.03 -0.78
(-0.63%)
JPY-INR
0.58 0.00
(-0.67%)

EQUITY - MARKET SCREENER

Mahanagar Telephone Nigam Ltd
Industry :  Telecommunications - Service Provider
BSE Code
ISIN Demat
Book Value()
500108
INE153A01019
-457.3346032
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MTNL
0
1540.98
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

vipul ltd
Alembic Pharmaceuticals receives USFDA approval for Carbidopa, Levodopa and Entacapone Tablets
Feb 06,2026

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbidopa, Levodopa and Entacapone Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25 mg/100 mg/200 mg, 31.25 mg/125 mg/200 mg, 37.5 mg/150 mg/200 mg, and 50 mg/200 mg/200 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Stalevo Tablets, 12.5 mg/50 mg/200 mg, 18.75 mg/75 mg/200 mg, 25 mg/100 mg/200 mg, 31.25 mg/125 mg/200 mg, 37.5 mg/150 mg/200 mg, and 50 mg/200 mg/200 mg, of Orion Corporation.

Carbidopa, levodopa and entacapone tablets are indicated for the treatment of Parkinson's disease.